BKR

Read This to Understand Baker Hughes Company Stock

Today we're going to take a closer look at large-cap Industrials company Baker Hughes Company, whose shares are currently trading at $34.05. We've been asking ourselves whether the company is under or over valued at today's prices... let's perform a brief value analysis to find out!

Baker Hughes Company's Valuation Is in Line With Its Sector Averages:

Baker Hughes Company provides a portfolio of technologies and services to energy and industrial value chain worldwide. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 20.49 and an average price to book (P/B) ratio of 3.78. In contrast, Baker Hughes Company has a trailing 12 month P/E ratio of 20.4 and a P/B ratio of 2.25.

When we divideBaker Hughes Company's P/E ratio by its expected five-year EPS growth rate, we obtain a PEG ratio of 0.53, which indicates that the market is undervaluing the company's projected growth (a PEG ratio of 1 indicates a fairly valued company). Your analysis of the stock shouldn't end here. Rather, a good PEG ratio should alert you that it may be worthwhile to take a closer look at the stock.

Shareholders Are Confronted With Declining EPS Growth:

2018 2019 2020 2021 2022 2023
Revenue (MM) $22,877 $23,838 $20,705 $20,502 $21,156 $23,305
Gross Margins 3% 5% -77% 6% 6% 14%
Operating Margins 3.0% 5.0% -73.0% 6.0% 6.0% 8.0%
Net Margins 1.0% 1.0% -28.0% -1.0% 0.0% 5.0%
Net Income (MM) $283 $271 -$5,821 -$111 $23 $1,174
Net Interest Expense (MM) $202 -$84 $1,040 -$299 -$252 $231
Depreciation & Amort. (MM) $1,486 $1,418 $1,317 $1,105 $1,061 $1,054
Free Cash Flow (MM) $767 $886 $330 $1,518 $899 $1,733
Capital Expenditures (MM) $995 $1,240 $974 $856 $989 $1,082
Net Current Assets (MM) $3,955 $2,675 $3,591 $3,303 $1,111 $1,071
Long Term Debt (MM) $6,285 $6,301 $6,744 $6,687 $5,980 $5,847
Net Debt / EBITDA 1.19 1.35 -0.2 1.19 1.68 1.31

Baker Hughes Company has weak revenue growth and a flat capital expenditure trend, similar gross margins to its peers, and irregular cash flows. We also note that the company has healthy leverage working in its favor. However, the firm suffers from consistently negative margins with a positive growth rate and declining EPS growth.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS